SMAD2 and cervical cancer: Additionally, bta-miR-484 has been observed to prevent cell proliferation and epithelial–mesenchymal transition process by targeting both ZEB1 and SMAD2 genes, thus functions like a tumor suppressor and may serve as a prospective biomarker for cervical cancer [64].